Heterogeneous nuclear ribonucleoprotein A1 is identified as a potential biomarker for colorectal cancer based on differential proteomics technology.
about
PSMB8 and PBK as potential gastric cancer subtype-specific biomarkers associated with prognosis.Facile preparation of doxorubicin-loaded upconversion@polydopamine nanoplatforms for simultaneous in vivo multimodality imaging and chemophotothermal synergistic therapy.Autoantibody signatures involving glycolysis and splicesome proteins precede a diagnosis of breast cancer among postmenopausal women.Chemical proteomics identifies heterogeneous nuclear ribonucleoprotein (hnRNP) A1 as the molecular target of quercetin in its anti-cancer effects in PC-3 cells.The proteomics of colorectal cancer: identification of a protein signature associated with prognosis.The cancerous translation apparatusAn informatics-assisted label-free approach for personalized tissue membrane proteomics: case study on colorectal cancer.Mechanistic control of carcinoembryonic antigen-related cell adhesion molecule-1 (CEACAM1) splice isoforms by the heterogeneous nuclear ribonuclear proteins hnRNP L, hnRNP A1, and hnRNP M.iTRAQ analysis of colorectal cancer cell lines suggests Drebrin (DBN1) is overexpressed during liver metastasis.EGF-Induced Acetylation of Heterogeneous Nuclear Ribonucleoproteins Is Dependent on KRAS Mutational Status in Colorectal Cancer Cells.The Kinetic Response of the Proteome in A549 Cells Exposed to ZnSO4 StressHistidine decarboxylase is identified as a potential biomarker of intestinal mucosal injury in patients with acute intestinal obstruction.Comparative expression patterns and diagnostic efficacies of SR splicing factors and HNRNPA1 in gastric and colorectal cancerTranslational control in cancer etiology.Ethanol and Cancer Induce Similar Changes on Protein Expression Pattern of Human Fibroblast Cell.Lipid rafts: signaling and sorting platforms of cells and their roles in cancer.Searching for consistently reported up- and down-regulated biomarkers in colorectal cancer: a systematic review of proteomic studies.Developing proteomics-based biomarkers for colorectal neoplasms for clinical practice: opportunities and challenges.Serum proteomics in biomedical research: a systematic review.Proteomics, genomics and transcriptomics: their emerging roles in the discovery and validation of colorectal cancer biomarkers.Proteomics for discovery of candidate colorectal cancer biomarkers.Splicing factor hnRNP A2 activates the Ras-MAPK-ERK pathway by controlling A-Raf splicing in hepatocellular carcinoma developmentMolecular biomarkers in colorectal carcinoma.Biomarker discovery by proteomics-based approaches for early detection and personalized medicine in colorectal cancer.hnRNPA1 couples nuclear export and translation of specific mRNAs downstream of FGF-2/S6K2 signalling.A possible role of transglutaminase 2 in the nucleus of INS-1E and of cells of human pancreatic isletsTranscriptional analysis of hnRNPA0, A1, A2, B1, and A3 in lung cancer cell lines in response to acidosis, hypoxia, and serum deprivation conditions.Overexpression of HnRNP A1 promotes tumor invasion through regulating CD44v6 and indicates poor prognosis for hepatocellular carcinoma.Expression Profile of Three Splicing Factors in Pleural Cells Based on the Underlying Etiology and Its Clinical Values in Patients with Pleural Effusion.
P2860
Q27853348-12BA5D07-3693-4D7F-8340-649860B253D9Q30874165-A8E9396C-C8A0-4768-AFC2-EE5EFCFCAE54Q33859258-8CF16F37-42FC-4F71-B6D5-A4CB7C06B01EQ34070388-C39FF4D8-9CB1-4FC8-ACE1-AD4FF9F7E152Q34085776-56AA7824-97AA-4B87-AF95-66F27D185E33Q34182649-35732F45-2944-4BC9-A36D-FAE3145BE78CQ34751614-6CC79DD8-8AAF-4C74-B43B-2B20824225BEQ34963359-116A33D6-488D-466D-A739-01984414F030Q35115084-C3B5D22C-1F8B-47FC-B951-746BC6E4322DQ35674250-AF78F073-6F8C-487C-A25B-4D265DC5FF48Q35702298-D51A411F-5483-4BC4-94C8-0C93C43502F5Q35876764-54DBD38D-7B2D-4A81-A88F-0DE6211EBE1FQ36047336-9C9501E4-3FA1-4CE9-B5B6-904FBD72A432Q36555212-5EECA2F5-A30E-4E8C-BEF9-104FE6AB0F42Q37592091-B697580F-02A1-40AD-8484-E0730D19E487Q37866316-50D370D2-4B92-4537-958D-81D5D6A15937Q38018848-0D2958D5-BBB5-49D0-94FE-831593A55C97Q38068828-676B0A5F-6C74-4290-96AC-61D351C86D5BQ38101008-5FE08EBF-EFB6-45C8-84CA-0C88B001DCCCQ38194582-343F91A3-1EC2-4FB3-A61E-44FA43F4F9DBQ38205429-1CF5824F-3539-4329-A66B-936E39909702Q38487106-F9C54C35-7907-4BFF-A210-54181ABA0E86Q38559669-D495023B-75A2-46F4-A5C8-60EB7511E5A7Q38778051-24A093DA-933D-4375-A336-986E37B27E36Q38946989-F1E9943B-141C-42FC-B249-6EAC81C26110Q39051827-1EDE3C0A-65D3-40CB-8153-12D2ED3EB9DCQ39061832-193E9E45-B5FE-42CA-82CE-C4112FD459C0Q39310276-065AAA21-0AB7-4993-A318-D333CE155A34Q49390020-FD9E0CCB-7991-4A18-9F4A-CFABC98A988F
P2860
Heterogeneous nuclear ribonucleoprotein A1 is identified as a potential biomarker for colorectal cancer based on differential proteomics technology.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Heterogeneous nuclear ribonucl ...... rential proteomics technology.
@ast
Heterogeneous nuclear ribonucl ...... rential proteomics technology.
@en
type
label
Heterogeneous nuclear ribonucl ...... rential proteomics technology.
@ast
Heterogeneous nuclear ribonucl ...... rential proteomics technology.
@en
prefLabel
Heterogeneous nuclear ribonucl ...... rential proteomics technology.
@ast
Heterogeneous nuclear ribonucl ...... rential proteomics technology.
@en
P2093
P921
P356
P1476
Heterogeneous nuclear ribonucl ...... rential proteomics technology.
@en
P2093
Hong-Qi Chen
Huan-Long Qin
Jia-Yuan Peng
Long Huang
Ming Zhang
Peng Zhang
Tong-Yi Shen
Wei-Jie Liu
Yan-Lei Ma
Yu-Kun Zhou
P304
P356
10.1021/PR900365E
P577
2009-10-01T00:00:00Z